263 related articles for article (PubMed ID: 8397008)
1. Stimulation of the adenylyl cyclase activity in human endometrial membranes by VIP and related peptides.
Bajo AM; Guijarro LG; Juarranz MG; Valenzuela P; Martinez P; Prieto JC
Biosci Rep; 1993 Apr; 13(2):69-77. PubMed ID: 8397008
[TBL] [Abstract][Full Text] [Related]
2. Characterization of adenylyl cyclase stimulated by VIP in rat and mouse peritoneal macrophage membranes.
Pozo D; Segura JJ; Carrero I; Guijarro LG; Prieto JC; Calvo JR
Biochim Biophys Acta; 1996 Jul; 1312(3):249-54. PubMed ID: 8703995
[TBL] [Abstract][Full Text] [Related]
3. A new type of functional VIP receptor has an affinity for helodermin in human SUP-T1 lymphoblasts.
Robberecht P; Waelbroeck M; De Neef P; Tastenoy M; Gourlet P; Cogniaux J; Christophe J
FEBS Lett; 1988 Feb; 228(2):351-5. PubMed ID: 2830146
[TBL] [Abstract][Full Text] [Related]
4. Characterization of binding sites for VIP-related peptides and activation of adenylate cyclase in developing pancreas.
Le Meuth V; Farjaudon N; Bawab W; Chastre E; Rosselin G; Guilloteau P; Gespach C
Am J Physiol; 1991 Feb; 260(2 Pt 1):G265-74. PubMed ID: 1847591
[TBL] [Abstract][Full Text] [Related]
5. Secretin receptors in human pancreatic membranes.
Robberecht P; De Neef P; Waelbroeck M; Camus JC; Scemama JL; Fourmy D; Pradayrol L; Vaysse N; Christophe J
Pancreas; 1988; 3(5):529-35. PubMed ID: 3186683
[TBL] [Abstract][Full Text] [Related]
6. Adenylyl cyclase stimulation by VIP in rat seminal vesicle membranes.
Rodriguez-Pena MS; Guijarro LG; Prieto JC
Peptides; 1991; 12(4):821-4. PubMed ID: 1664946
[TBL] [Abstract][Full Text] [Related]
7. [D-Phe4]peptide histidine-isoleucinamide ([D-Phe4]PHI), a highly selective vasoactive-intestinal-peptide (VIP) agonist, discriminates VIP-preferring from secretin-preferring receptors in rat pancreatic membranes.
Robberecht P; Coy DH; De Neef P; Camus JC; Cauvin A; Waelbroeck M; Christophe J
Eur J Biochem; 1987 Jun; 165(2):243-9. PubMed ID: 3036504
[TBL] [Abstract][Full Text] [Related]
8. Vasoactive intestinal peptide stimulation of human renal adenylate cyclase in vitro.
Charlton BG; Neal DE; Simmons NL
J Physiol; 1990 Apr; 423():475-84. PubMed ID: 2167366
[TBL] [Abstract][Full Text] [Related]
9. Pharmacology, molecular identification and functional characteristics of vasoactive intestinal peptide receptors in human breast cancer cells.
Gespach C; Bawab W; de Cremoux P; Calvo F
Cancer Res; 1988 Sep; 48(18):5079-83. PubMed ID: 2842044
[TBL] [Abstract][Full Text] [Related]
10. Characterization of vasoactive intestinal peptide receptors in human liver.
Rodríguez-Henche N; Rodríguez-Pena MS; Guijarro LG; Prieto JC
Biochim Biophys Acta; 1994 Mar; 1221(2):193-8. PubMed ID: 8148398
[TBL] [Abstract][Full Text] [Related]
11. Homologous regulation of adenylate cyclase-coupled receptors for vasoactive intestinal peptide (VIP) on human mononuclear leucocytes.
Wiik P
Regul Pept; 1988 Apr; 20(4):323-33. PubMed ID: 2835796
[TBL] [Abstract][Full Text] [Related]
12. Analysis of vasoactive intestinal peptide receptors and the G protein regulation of adenylyl cyclase in seminal vesicle membranes from streptozotocin-diabetic rats.
Rodriguez-Pena MS; Guijarro LG; Juarranz MG; Rodriguez-Henche N; Bajo AM; Aguado F; Prieto JC
Cell Signal; 1994 Feb; 6(2):147-56. PubMed ID: 8086277
[TBL] [Abstract][Full Text] [Related]
13. Properties of vasoactive-intestinal-peptide receptors and beta-adrenoceptors in the murine radiation leukemia-virus-induced lymphoma cell line BL/VL3.
Abello J; Damien C; De Neef P; Tastenoy M; Hooghe R; Robberecht P; Christophe J
Eur J Biochem; 1989 Aug; 183(2):263-7. PubMed ID: 2547606
[TBL] [Abstract][Full Text] [Related]
14. Receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide in turkey cerebral cortex: characterization by [125I]-VIP binding and effects on cyclic AMP synthesis.
Zawilska JB; Niewiadomski P; Nowak JZ
Gen Comp Endocrinol; 2004 Jun; 137(2):187-95. PubMed ID: 15158130
[TBL] [Abstract][Full Text] [Related]
15. Characterization of a common VIP-PACAP receptor in human small intestinal epithelium.
Salomon R; Couvineau A; Rouyer-Fessard C; Voisin T; Lavallée D; Blais A; Darmoul D; Laburthe M
Am J Physiol; 1993 Feb; 264(2 Pt 1):E294-300. PubMed ID: 8383439
[TBL] [Abstract][Full Text] [Related]
16. Heart receptors for VIP, PHI and secretin are able to activate adenylate cyclase and to mediate inotropic and chronotropic effects. Species variations and physiopathology.
Christophe J; Waelbroeck M; Chatelain P; Robberecht P
Peptides; 1984; 5(2):341-53. PubMed ID: 6089134
[TBL] [Abstract][Full Text] [Related]
17. Interaction of vasoactive intestinal peptide with a cell line (HeLa) derived from human carcinoma of the cervix: binding to specific sites and stimulation of adenylate cyclase.
Prieto JC; Guerrero JM; de Miguel C; Goberna R
Mol Cell Biochem; 1981 Jul; 37(3):167-76. PubMed ID: 6268963
[TBL] [Abstract][Full Text] [Related]
18. VIP receptors in human SUP-T1 lymphoblasts.
Christophe J; Cauvin A; Vervisch E; Buscail L; Damien C; Abello J; Gourlet P; Robberecht P
Digestion; 1990; 46 Suppl 2():148-55. PubMed ID: 1979777
[TBL] [Abstract][Full Text] [Related]
19. Vasoactive intestinal peptide (VIP) and peptide having N-terminal histidine and C-terminal isoleucine amide (PHI) stimulate adenylate cyclase activity in human heart membranes.
Taton G; Chatelain P; Delhaye M; Camus JC; De Neef P; Waelbroeck M; Tatemoto K; Robberecht P; Christophe J
Peptides; 1982; 3(6):897-900. PubMed ID: 6897744
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological characterization of the novel helodermin/VIP receptor present in human SUP-T1 lymphoma cell membranes.
Robberecht P; De Neef P; Gourlet P; Cauvin A; Coy DH; Christophe J
Regul Pept; 1989; 26(2):117-26. PubMed ID: 2552509
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
